BenjaminRobinSchrankMDPhD
Radiation Oncology • Houston, TXResident at UT MD Anderson Cancer Center (Radiation Oncology)
Dr. Schrank is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MD Anderson Cancer Center
Houston, TX 77030
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2021 - 2025
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2020 - 2021
Columbia University Vagelos College of Physicians and SurgeonsClass of 2020, MD, PhD
Publications & Presentations
PubMed
- An antibody-toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy.Benjamin R Schrank, Yifan Wang, Annette Wu, Nhat Tran, DaeYong Lee
Nature Cancer. 2025-03-01 - Genomic Biomarkers Predict Response to Combined ATR Inhibition and Radiotherapy.Benjamin R Schrank, Lauren E Colbert
Clinical Cancer Research. 2024-12-16 - Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung.Susan Y Wu, Penny Q Fang, Ahmed Fetooh, Gohar S Manzar, Kelsey L Corrigan
Advances in Radiation Oncology. 2024-12-01
Journal Articles
- Nuclear ARP2/3 Drives DNA Break Clustering for Homology-Directed RepairBenjamin Schrank, MD, Nature
Press Mentions
Novel Antibody-Toxin Conjugate (ATC) Prompts Immune System to Eliminate TumorsFebruary 26th, 2025- MD Anderson Unveils New Antibody-Toxin ConjugateFebruary 26th, 2025
- Novel Cancer Treatment Uses Bacterial Toxin to Train Immune SystemFebruary 25th, 2025
- Join now to see all
Professional Memberships
- American Society for Radiation OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
